[1]
BEGUM, S. et al. 2026. DESIGN CHARACTERIZATION OPTIMIZATION OF LENALIDOMIDE-LOADED BOVINE SERUM ALBUMIN NANOPARTICLES FOR MYELOMA THERAPY. International Journal of Applied Pharmaceutics. 18, 1 (Jan. 2026), 401–409. DOI:https://doi.org/10.22159/ijap.2026v18i1.55623.